Farin Kamangar to Opioid-Related Disorders
This is a "connection" page, showing publications Farin Kamangar has written about Opioid-Related Disorders.
Connection Strength
1.724
-
Kamangar F, Shakeri R, Malekzadeh R, Islami F. Opium use: an emerging risk factor for cancer? Lancet Oncol. 2014 Feb; 15(2):e69-77.
Score: 0.411
-
Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, Abaie B, Islami F, Nasseri-Moghaddam S, Etemadi A, Byrnes G, Abnet CC, Dawsey SM, Day NE, Pharoah PD, Boffetta P, Brennan P, Kamangar F. Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ. 2012 Apr 17; 344:e2502.
Score: 0.363
-
Alvand S, Amin-Esmaeili M, Poustchi H, Roshandel G, Sadeghi Y, Sharifi V, Kamangar F, Dawsey SM, Freedman ND, Abnet CC, Rahimi-Movaghar A, Malekzadeh R, Etemadi A. Prevalence and determinants of opioid use disorder among long-term opiate users in Golestan Cohort Study. BMC Psychiatry. 2023 12 21; 23(1):958.
Score: 0.204
-
Sheikh M, Kamangar F, Malekzadeh R. Fifty Years of Research and One Conclusion: Opium Causes Cancer. Arch Iran Med. 2020 11 01; 23(11):757-760.
Score: 0.164
-
Mohebbi E, Kamangar F, Rahimi-Movaghar A, Haghdoost AA, Etemadi A, Amirzadeh S, Najafi F, Shafeie F, Fakhari A, Ghaleban K, Shahid-Sales S, Hosseini ZS, Honarvar MR, Majnooni F, Hadji M, Zendehdel K. An Exploratory Study of Units of Reporting Opium Usein Iran: Implications for Epidemiologic Studies. Arch Iran Med. 2019 10 01; 22(10):541-545.
Score: 0.152
-
Rashidian H, Hadji M, Marzban M, Gholipour M, Rahimi-Movaghar A, Kamangar F, Malekzadeh R, Weiderpass E, Rezaianzadeh A, Moradi A, Babhadi-Ashar N, Ghiasvand R, Khavari-Daneshvar H, Haghdoost AA, Zendehdel K. Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients. PLoS One. 2017; 12(8):e0183017.
Score: 0.132
-
Khademi H, Kamangar F, Brennan P, Malekzadeh R. Opioid Therapy and its Side Effects: A Review. Arch Iran Med. 2016 Dec; 19(12):870-876.
Score: 0.125
-
Islami F, Nasseri-Moghaddam S, Pourshams A, Poustchi H, Semnani S, Kamangar F, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharoah PD, Brennan P, Abnet CC, Boffetta P, Malekzadeh R. Determinants of gastroesophageal reflux disease, including hookah smoking and opium use- a cross-sectional analysis of 50,000 individuals. PLoS One. 2014; 9(2):e89256.
Score: 0.103
-
Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, Brennan P, Taylor PR, Kamangar F, Dawsey SM, Malekzadeh R. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):1068-70.
Score: 0.053
-
Islami F, Kamangar F, Nasrollahzadeh D, M?ller H, Boffetta P, Malekzadeh R. Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer. 2009 Dec; 45(18):3156-65.
Score: 0.019